Cover Image
市場調查報告書

Phenex Pharmaceuticals AG的產品平台分析

Phenex Pharmaceuticals AG - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 312701
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
Phenex Pharmaceuticals AG的產品平台分析 Phenex Pharmaceuticals AG - Product Pipeline Review - 2014
出版日期: 2014年09月10日 內容資訊: 英文 27 Pages
簡介

Phenex Pharmaceuticals AG是總公司位於德國的新藥開發公司,發現了可用於荷爾蒙替代療法、女性醫療、發炎、糖尿病、癌症、皮膚疾病等領域藥物研發之核受體。

本報告提供Phenex Pharmaceuticals AG的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Phenex Pharmaceuticals AG的基本資料

  • Phenex Pharmaceuticals AG概要
  • 主要資訊
  • 企業資料

Phenex Pharmaceuticals AG:R&D概要

  • 主要的治療範圍

Phenex Pharmaceuticals AG:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Phenex Pharmaceuticals AG:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Phenex Pharmaceuticals AG:藥物簡介

  • Px-102
  • Px-104
  • Px-103
  • PX-20606
  • Retinoid-Acid Receptor Related Orphan Receptor Gamma T Program

Phenex Pharmaceuticals AG:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Phenex Pharmaceuticals AG:最新的開發平台資訊

Phenex Pharmaceuticals AG:暫停中的計劃

Phenex Pharmaceuticals AG:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

目錄
Product Code: GMDHC06406CDB

Summary

Global Markets Direct's, 'Phenex Pharmaceuticals AG - Product Pipeline Review - 2014', provides an overview of the Phenex Pharmaceuticals AG's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Phenex Pharmaceuticals AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Phenex Pharmaceuticals AG including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Phenex Pharmaceuticals AG's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Phenex Pharmaceuticals AG's pipeline products

Reasons to buy

  • Evaluate Phenex Pharmaceuticals AG's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Phenex Pharmaceuticals AG in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Phenex Pharmaceuticals AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Phenex Pharmaceuticals AG and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Phenex Pharmaceuticals AG
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Phenex Pharmaceuticals AG and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Phenex Pharmaceuticals AG Snapshot
    • Phenex Pharmaceuticals AG Overview
    • Key Information
    • Key Facts
  • Phenex Pharmaceuticals AG - Research and Development Overview
    • Key Therapeutic Areas
  • Phenex Pharmaceuticals AG - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Phenex Pharmaceuticals AG - Pipeline Products Glance
    • Phenex Pharmaceuticals AG - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Phenex Pharmaceuticals AG - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Phenex Pharmaceuticals AG - Drug Profiles
    • Px-102
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Px-104
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Px-103
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PX-20606
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Retinoid-Acid Receptor Related Orphan Receptor Gamma T Program
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Phenex Pharmaceuticals AG - Pipeline Analysis
    • Phenex Pharmaceuticals AG - Pipeline Products by Target
    • Phenex Pharmaceuticals AG - Pipeline Products by Route of Administration
    • Phenex Pharmaceuticals AG - Pipeline Products by Molecule Type
    • Phenex Pharmaceuticals AG - Pipeline Products by Mechanism of Action
  • Phenex Pharmaceuticals AG - Recent Pipeline Updates
  • Phenex Pharmaceuticals AG - Dormant Projects
  • Phenex Pharmaceuticals AG - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Phenex Pharmaceuticals AG, Key Information
  • Phenex Pharmaceuticals AG, Key Facts
  • Phenex Pharmaceuticals AG - Pipeline by Indication, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Stage of Development, 2014
  • Phenex Pharmaceuticals AG - Monotherapy Products in Pipeline, 2014
  • Phenex Pharmaceuticals AG - Phase II, 2014
  • Phenex Pharmaceuticals AG - Phase I, 2014
  • Phenex Pharmaceuticals AG - Preclinical, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Target, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Route of Administration, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Molecule Type, 2014
  • Phenex Pharmaceuticals AG - Pipeline Products by Mechanism of Action, 2014
  • Phenex Pharmaceuticals AG - Recent Pipeline Updates, 2014
  • Phenex Pharmaceuticals AG - Dormant Developmental Projects,2014
  • Phenex Pharmaceuticals AG, Other Locations

List of Figures

  • Phenex Pharmaceuticals AG - Pipeline by Top 10 Indication, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Stage of Development, 2014
  • Phenex Pharmaceuticals AG - Monotherapy Products in Pipeline, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Top 10 Target, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Top 10 Route of Administration, 2014
  • Phenex Pharmaceuticals AG - Pipeline by Top 10 Molecule Type, 2014
  • Phenex Pharmaceuticals AG - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top